| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 133.81B | 138.16B | 132.28B | 125.08B | 119.18B | 117.75B |
| Gross Profit | 44.15B | 44.11B | 42.65B | 41.62B | 37.88B | 37.35B |
| EBITDA | 21.55B | 22.03B | 21.63B | 21.50B | 18.60B | 19.28B |
| Net Income | 12.90B | 12.94B | 13.11B | 13.19B | 9.97B | 9.05B |
Balance Sheet | ||||||
| Total Assets | 256.08B | 273.09B | 267.25B | 269.82B | 236.53B | 228.98B |
| Cash, Cash Equivalents and Short-Term Investments | 70.61B | 73.06B | 78.71B | 90.62B | 76.89B | 75.82B |
| Total Debt | 450.00M | 250.00M | 745.00M | 989.00M | 1.27B | 1.64B |
| Total Liabilities | 40.49B | 51.63B | 43.95B | 49.93B | 40.14B | 41.31B |
| Stockholders Equity | 188.43B | 201.82B | 195.22B | 187.15B | 166.27B | 160.29B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 13.63B | 883.00M | 15.35B | 7.00B | 10.05B |
| Operating Cash Flow | 0.00 | 25.40B | 12.01B | 22.78B | 16.61B | 14.28B |
| Investing Cash Flow | 0.00 | 864.00M | -16.28B | -5.78B | -12.30B | -6.66B |
| Financing Cash Flow | 0.00 | -26.10B | -15.23B | -6.78B | -9.16B | -4.11B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥180.84B | 22.82 | ― | 2.84% | 4.10% | 5.25% | |
77 Outperform | ¥176.43B | 12.35 | ― | 3.50% | 4.44% | 4.49% | |
73 Outperform | ¥69.62B | 51.71 | ― | 1.52% | 6.15% | 73.57% | |
69 Neutral | ¥2.40T | 11.00 | 11.64% | 1.52% | 11.97% | 45.59% | |
64 Neutral | ¥437.97B | 4.51 | 8.14% | 2.61% | -0.45% | 50.53% | |
63 Neutral | ¥395.07B | 13.04 | 13.71% | 3.38% | 0.16% | -12.55% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |